Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Familial amyloidosis].

G Grateau1, M E Roux

  • 1Département de Médecine interne, Hôpital Cochin, Paris.

Presse Medicale (Paris, France : 1983)
|November 7, 1992
PubMed
Summary
This summary is machine-generated.

Familial amyloidosis presents diverse clinical and genetic forms, often involving amyloidotic neuropathy. Understanding transthyretin deposition advances knowledge of this heterogeneous disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

French protocol for the diagnosis and management of familial Mediterranean fever.

La Revue de medecine interne·2023
Same author

French practical guidelines for the diagnosis and management of AA amyloidosis.

La Revue de medecine interne·2023
Same author

Poor performance of albumin or protein-adjusted plasma calcium to diagnose dyscalcemia in hospitalized patients: A confirmatory study in a general internal medicine department.

La Revue de medecine interne·2021
Same author

Tattooing and autoinflammatory diseases: a study among 197 French patients from the JIR cohort.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Is neutrophilic dermatosis a manifestation of familial Mediterranean fever?

Scandinavian journal of rheumatology·2021
Same author

[Periodic fever syndrome associated with mutations in the TNF type 1 receptor gene: A differential diagnosis of familial Mediterranean fever that should not be overlooked in patients of Mediterranean origin].

La Revue de medecine interne·2020
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Area of Science:

  • Genetics
  • Molecular Biology
  • Medicine

Context:

  • Familial amyloidosis exhibits significant clinical and genetic variability.
  • Amyloidotic neuropathy is the most common type, linked to various amyloid protein deposits.
  • Other forms affect organs like the kidney, heart, eye, and skin.

Purpose:

  • To explore the heterogeneity of familial amyloidosis.
  • To identify the genetic basis of different amyloidosis subtypes.
  • To understand the role of specific amyloid proteins and mutations.

Summary:

  • Familial amyloidosis is a heterogeneous group of diseases with diverse clinical presentations and genetic causes.
  • Amyloidotic neuropathy, the most frequent form, can result from mutations in genes encoding transthyretin, apolipoprotein A1, or gelsolin.

Related Experiment Videos

  • Other forms involve distinct organ systems and may or may not be associated with mutations in the amyloid protein itself.

    • Impact:

    • Advances in understanding transthyretin deposition are crucial for broader insights into amyloidosis.
    • Improved knowledge can lead to better diagnostics and targeted therapies for familial amyloidosis.
    • Elucidating genetic heterogeneity aids in personalized medicine approaches for affected families.